ID
37354
Beschreibung
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form contains details on the administration of the investigational product and is to be filled in at Day 1, 2 and 3. Additionally, this form also contains Randomisation information and the assignment of the participant to one of the four cohorts for/prior to the first medication administration.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Stichworte
Versionen (2)
- 16.07.19 16.07.19 -
- 20.07.19 20.07.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
20. Juli 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
SB-681323 in ALI/ARDS risk patients - NCT00996840
Investigational Product - IV Dosing, Randomisation, Cohort Assignment
Beschreibung
First Administration
Alias
- UMLS CUI-1
- C3469597 (Administration of medication)
- SNOMED
- 18629005
Beschreibung
Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24hrs
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0449238 (Duration (temporal concept))
- SNOMED
- 762636008
- LOINC
- LP14744-4
- UMLS CUI [1,2]
- C3469597 (Administration of medication)
- SNOMED
- 18629005
- UMLS CUI [1,3]
- C0304229 (Experimental drug)
Beschreibung
Start Date and Time
Datentyp
datetime
Alias
- UMLS CUI [1]
- C3897500 (Start Date and Time of Procedure)
Beschreibung
Stop Date and Time
Datentyp
datetime
Alias
- UMLS CUI [1]
- C3899266 (End Date and Time of Procedure)
Beschreibung
Volume administered
Datentyp
float
Maßeinheiten
- mL
Alias
- UMLS CUI [1]
- C2349139 (Volume Administered)
Beschreibung
Administration post interruption
Alias
- UMLS CUI-1
- C3469597 (Administration of medication)
- SNOMED
- 18629005
- UMLS CUI-2
- C0687676 (Post)
- SNOMED
- 288563008
- LOINC
- LP20512-7
- UMLS CUI-3
- C1512900 (Interruption)
Beschreibung
Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24 hrs
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0449238 (Duration (temporal concept))
- SNOMED
- 762636008
- LOINC
- LP14744-4
- UMLS CUI [1,2]
- C3469597 (Administration of medication)
- SNOMED
- 18629005
- UMLS CUI [1,3]
- C0304229 (Experimental drug)
Beschreibung
Start Date and Time
Datentyp
datetime
Alias
- UMLS CUI [1]
- C3897500 (Start Date and Time of Procedure)
Beschreibung
Stop Date and Time
Datentyp
datetime
Alias
- UMLS CUI [1]
- C3899266 (End Date and Time of Procedure)
Beschreibung
Volume administered
Datentyp
float
Maßeinheiten
- mL
Alias
- UMLS CUI [1]
- C2349139 (Volume Administered)
Beschreibung
Investigational Product Container Number
Alias
- UMLS CUI-1
- C0304229 (Experimental drug)
- UMLS CUI-2
- C0180098 (Containers)
- SNOMED
- 706437002
- UMLS CUI-3
- C0600091 (Identifier)
- SNOMED
- 118522005
- LOINC
- LP31795-5
Beschreibung
Record the identifying number from the investigational product container dispensed at this visit
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0304229 (Experimental drug)
- UMLS CUI [1,2]
- C0180098 (Containers)
- SNOMED
- 706437002
- UMLS CUI [1,3]
- C0600091 (Identifier)
- SNOMED
- 118522005
- LOINC
- LP31795-5
Beschreibung
Treatment Confirmation
Alias
- UMLS CUI-1
- C0750484 (Confirmation)
- LOINC
- LA15290-2
- UMLS CUI-2
- C0087111 (Therapeutic procedure)
- SNOMED
- 277132007
- LOINC
- LP21090-3
Beschreibung
If no, record reasons
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0087111 (Therapeutic procedure)
- SNOMED
- 277132007
- LOINC
- LP21090-3
- UMLS CUI [1,2]
- C2349182 (Correct (qualifier))
- LOINC
- LA9960-1
Beschreibung
if applicable
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0566251 (Reason and justification)
- SNOMED
- 288830005
- UMLS CUI [1,2]
- C0087111 (Therapeutic procedure)
- SNOMED
- 277132007
- LOINC
- LP21090-3
- UMLS CUI [1,3]
- C3827420 (Wrong)
- LOINC
- LA7342-4
Beschreibung
Randomisation Number
Alias
- UMLS CUI-1
- C0034656 (Randomization)
- UMLS CUI-2
- C0237753 (Numbers)
- SNOMED
- 260299005
- LOINC
- LP6841-3
Beschreibung
If yes, provide Randomisation Number and Date/time of randomisation
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0034656 (Randomization)
- UMLS CUI [1,2]
- C0332149 (Possible)
- SNOMED
- 371930009
- LOINC
- LA15097-1
Beschreibung
if applicable
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0034656 (Randomization)
- UMLS CUI [1,2]
- C0237753 (Numbers)
- SNOMED
- 260299005
- LOINC
- LP6841-3
Beschreibung
if applicable
Datentyp
datetime
Alias
- UMLS CUI [1,1]
- C0034656 (Randomization)
- UMLS CUI [1,2]
- C1264639 (Date/Time)
- SNOMED
- 118575009
Ähnliche Modelle
Investigational Product - IV Dosing, Randomisation, Cohort Assignment
C1516050 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,3])
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0687676 (UMLS CUI-2)
C1512900 (UMLS CUI-3)
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0180098 (UMLS CUI-2)
C0600091 (UMLS CUI-3)
C0180098 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
C0087111 (UMLS CUI-2)
C2349182 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C3827420 (UMLS CUI [1,3])
C0332149 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,2])
Keine Kommentare